Literature DB >> 8499410

Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms.

K Asai1, C Funaki, T Hayashi, K Yamada, M Naito, M Kuzuya, F Yoshida, N Yoshimine, F Kuzuya.   

Abstract

We investigated the mechanisms by which corticosteroids affect atherosclerosis. Male New Zealand White rabbits were injected with 0.125 mg dexamethasone (n = 10) or vehicle (control group, n = 10). Both groups were fed a 1% cholesterol diet for 8 weeks. Although the dexamethasone-treated animals exhibited a greater degree of hyperlipidemia, they exhibited significantly less atherosclerotic plaque of the aortic surface than control animals (7.8% versus 47.2%). Immunofluorescence study of the aortic plaque specimens showed that dexamethasone administration reduced both macrophages and T lymphocytes. In vitro, dexamethasone suppressed the proliferation and differentiation of U937 cells and inhibited uptake and degradation of beta-very low density lipoproteins by mouse peritoneal macrophages. These findings suggest that dexamethasone suppresses the development of atherosclerosis in the aorta of rabbits by inhibiting recruitment and proliferation of macrophages and the formation of foam cells in plaques.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499410     DOI: 10.1161/01.atv.13.6.892

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  27 in total

Review 1.  Detection and treatment of atherosclerosis using nanoparticles.

Authors:  Jia Zhang; Yujiao Zu; Chathurika S Dhanasekara; Jun Li; Dayong Wu; Zhaoyang Fan; Shu Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-31

2.  Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells.

Authors:  Latika Dhawan; Bin Liu; Allison Pytlak; Satyarth Kulshrestha; Burns C Blaxall; Mark B Taubman
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

Review 3.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

4.  Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.

Authors:  Brittany G Durgin; Olga A Cherepanova; Delphine Gomez; Themistoclis Karaoli; Gabriel F Alencar; Joshua T Butcher; Yu-Qing Zhou; Michelle P Bendeck; Brant E Isakson; Gary K Owens; Jessica J Connelly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-10       Impact factor: 4.733

Review 5.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 6.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

7.  Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice.

Authors:  Till Freudenberger; Marc Oppermann; Andrea Marzoll; Hans-Karl Heim; Peter Mayer; Georg Kojda; Artur A Weber; Karsten Schrör; Jens W Fischer
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

8.  Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma.

Authors:  Serkan Yener; Sinan Genc; Baris Akinci; Mustafa Secil; Tevfik Demir; Abdurrahman Comlekci; Senem Ertilav; Sena Yesil
Journal:  Endocrine       Date:  2009-03-10       Impact factor: 3.633

Review 9.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

10.  TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLES.

Authors:  Gaurav Sharma; Zhi-Gang She; David T Valenta; William B Stallcup; Jeffrey W Smith
Journal:  Nano Life       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.